Altered Monocytic Phenotypes are Associated with Uraemic Pruritus in Patients Receiving Haemodialysis
DOI:
https://doi.org/10.2340/00015555-3841Keywords:
cytokines, CD14 CD16 monocytes, haemodialysis, itch, intermediate monocytes, uraemic pruritusAbstract
Uraemic pruritus is one of the most bothersome symptoms in patients receiving haemodialysis. A total of 175 patients receiving maintenance haemodialysis, with 74 patients experiencing uraemic pruritus, were prospectively recruited to assess the influence of the phenotype of blood monocytes and various cytokines on uraemic pruritus. The phenotype of blood monocytes was determined by flow cytometry as classical (CD14++CD16−) monocytes, non-classical (CD14+CD16++) monocytes, and intermediate (CD14++CD16+) monocytes. Eight cytokines, including interleukin (IL)-2, interferon-γ, IL-12p70, IL-4, IL-5, IL-6, tumour necrosis factor-α, and IL-10, were simultaneously detected with a multiplex bead-based immunoassay. Multivariate linear regression analysis showed that a higher percentage of intermediate monocytes (effect estimate 0.08; 95% confidence interval 0.01–0.16) were independent predictors of a higher visual analogue scale score for pruritus intensity. No differences were noted for all 8 cytokines between patients with and without uraemic pruritus. The results of this study indicate that altered monocytic phenotypes could play a role in uraemic pruritus.
Downloads
References
Wu HY, Peng YS, Chen HY, Tsai WC, Yang JY, Hsu SP, et al. A comparison of uremic pruritus in patients receiving peritoneal dialysis and hemodialysis. Medicine (Baltimore) 2016; 95: e2935.
DOI: https://doi.org/10.1097/MD.0000000000002935
Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 1410-1419.
DOI: https://doi.org/10.2215/CJN.00100110
Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505.
DOI: https://doi.org/10.1093/ndt/gfl461
Simonsen E, Komenda P, Lerner B, Askin N, Bohm C, Shaw J, et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis 2017; 70: 638-655.
DOI: https://doi.org/10.1053/j.ajkd.2017.05.018
Ko MJ, Huang JW, Wu HY, Tsai WC, Hsu LY, Tsai PH, et al. Risk of skin cancer among patients with chronic kidney disease treated with ultraviolet B phototherapy for uraemic pruritus: a nationwide cohort Study. Acta Derm Venereol 2021; 101: adv00390.
DOI: https://doi.org/10.2340/00015555-3758
Ko MJ, Yang JY, Wu HY, Hu FC, Chen SI, Tsai PJ, et al. Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. Br J Dermatol 2011; 165: 633-639.
DOI: https://doi.org/10.1111/j.1365-2133.2011.10448.x
Ko MJ, Wu HY, Chen HY, Chiu YL, Hsu SP, Pai MF, et al. Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study. PLoS One 2013; 8: e71404.
DOI: https://doi.org/10.1371/journal.pone.0071404
Wikstrom B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, et al. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005; 16: 3742-3747.
DOI: https://doi.org/10.1681/ASN.2005020152
Wieczorek A, Krajewski P, Koziol-Galczynska M, Szepietowski JC. Opioid receptors expression in the skin of haemodialysis patients suffering from uraemic pruritus. J Eur Acad Dermatol Venereol 2020; 34: 2368-2372.
DOI: https://doi.org/10.1111/jdv.16360
Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications. Nephrol Dial Transplant 2011; 26: 3338-3344.
DOI: https://doi.org/10.1093/ndt/gfr053
Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 749-755.
DOI: https://doi.org/10.1093/ndt/gfi204
Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 1998; 78: 395-402.
DOI: https://doi.org/10.1159/000044967
Chiu YL, Chen HY, Chuang YF, Hsu SP, Lai CF, Pai MF, et al. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 3685-3689.
DOI: https://doi.org/10.1093/ndt/gfn303
Ko MJ, Peng YS, Chen HY, Hsu SP, Pai MF, Yang JY, et al. Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis. J Am Acad Dermatol 2014; 71: 1151-1159.
DOI: https://doi.org/10.1016/j.jaad.2014.08.004
Wu HY, Huang JW, Tsai WC, Peng YS, Chen HY, Yang JY, et al. Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: a prospective cohort study. PLoS One 2018; 13: e0203474.
DOI: https://doi.org/10.1371/journal.pone.0203474
Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Yang JY, et al. Elevated C-reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM 2010; 103: 837-846.
DOI: https://doi.org/10.1093/qjmed/hcq036
Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-e80.
DOI: https://doi.org/10.1182/blood-2010-02-258558
Wong KL, Tai JJ, Wong WC, Han H, Sem X, Yeap WH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118: e16-e31.
DOI: https://doi.org/10.1182/blood-2010-12-326355
Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthrit Rheum 2012; 64: 671-677.
DOI: https://doi.org/10.1002/art.33418
Zawada AM, Rogacev KS, Rotter B, Winter P, Marell R-R, Fliser D, et al. SuperSAGE evidence for CD14++ CD16+ monocytes as a third monocyte subset. Blood 2011; 118: e50-e61.
DOI: https://doi.org/10.1182/blood-2011-01-326827
Lee J, Tam H, Adler L, Ilstad-Minnihan A, Macaubas C, Mellins ED. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS One 2017; 12: e0183594.
DOI: https://doi.org/10.1371/journal.pone.0183594
Tsukamoto M, Seta N, Yoshimoto K, Suzuki K, Yamaoka K, Takeuchi T. CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis. Arthritis Res Ther 2017; 19: 28.
DOI: https://doi.org/10.1186/s13075-016-1216-6
Hung CH, Wang CC, Suen JL, Sheu CC, Kuo CH, Liao WT, et al. Altered pattern of monocyte differentiation and monocyte-derived TGF-?1 in severe asthma. Sci Rep 2018; 8: 919.
DOI: https://doi.org/10.1038/s41598-017-19105-z
Wildgruber M, Aschenbrenner T, Wendorff H, Czubba M, Glinzer A, Haller B, et al. The "Intermediate" CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans. Sci Rep 2016; 6: 39483.
DOI: https://doi.org/10.1038/srep39483
Hortova-Kohoutkova M, Laznickova P, Bendickova K, De Zuani M, Andrejcinova I, Tomaskova V, et al. Differences in monocyte subsets are associated with short-term survival in patients with septic shock. J Cell Mol Med 2020; 24: 12504-12512.
DOI: https://doi.org/10.1111/jcmm.15791
Chiu YL, Shu KH, Yang FJ, Chou TY, Chen PM, Lay FY, et al. A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study. Immun Ageing 2018; 15: 27.
DOI: https://doi.org/10.1186/s12979-018-0131-x
Mistik S, Utas S, Ferahbas A, Tokgoz B, Unsal G, Sahan H, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol 2006; 20: 672-678.
DOI: https://doi.org/10.1111/j.1468-3083.2006.01570.x
Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol 2001; 81: 108-111.
DOI: https://doi.org/10.1080/00015550152384236
Furue M, Ebata T, Ikoma A, Takeuchi S, Kataoka Y, Takamori K, et al. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Venereol 2013; 93: 214-215.
DOI: https://doi.org/10.2340/00015555-1446
Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304.
DOI: https://doi.org/10.1016/S1073-4449(12)80028-8
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015; 66: 884-930.
DOI: https://doi.org/10.1053/j.ajkd.2015.07.015
Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol 2006; 17 (12 Suppl 3): S274-S280.
DOI: https://doi.org/10.1681/ASN.2006080926
Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, et al. Inflammation modifies the paradoxical association between body mass index and mortality in hemodialysis patients. J Am Soc Nephrol 2016; 27: 1479-1486.
DOI: https://doi.org/10.1681/ASN.2015030252
Wong LS, Wu T, Lee CH. Inflammatory and noninflammatory itch: implications in pathophysiology-directed treatments. Int J Mol Sci 2017; 18: 1485.
DOI: https://doi.org/10.3390/ijms18071485
Sampath P, Moideen K, Ranganathan UD, Bethunaickan R. Monocyte subsets: phenotypes and function in tuberculosis infection. Front Immunol 2018; 9: 1726.
DOI: https://doi.org/10.3389/fimmu.2018.01726
Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, Reichart B, et al. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008; 73: 622-629.
DOI: https://doi.org/10.1038/sj.ki.5002744
Zawada AM, Schneider JS, Michel AI, Rogacev KS, Hummel B, Krezdorn N, et al. DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation. Epigenetics 2016; 11: 259-272.
DOI: https://doi.org/10.1080/15592294.2016.1158363
Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33: 375-386.
DOI: https://doi.org/10.1016/j.immuni.2010.08.012
Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 2016; 138: 984-1010.
DOI: https://doi.org/10.1016/j.jaci.2016.06.033
Lachmandas E, Boutens L, Ratter JM, Hijmans A, Hooiveld GJ, Joosten LA, et al. Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat Microbiol 2016; 2: 16246.
Published
How to Cite
License
Copyright (c) 2021 Mei-Ju Ko, Wan-Chuan Tsai, Yu-Sen Peng, Shih-Ping Hsu, Mei-Fen Pai, Ju-Yeh Yang, Hon-Yen Wu, Yen-Ling Chiu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
